Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Copper
Drug ID BADD_D00529
Description Copper is a transition metal and a trace element in the body. It is important to the function of many enzymes including cytochrome c oxidase, monoamine oxidase and superoxide dismutase [FDA Label]. Copper is commonly used in contraceptive intrauterine devices (IUD) [L801].
Indications and Usage For use in the supplementation of total parenteral nutrition and in contraception with intrauterine devices [FDA Label] [L801].
Marketing Status approved; investigational
ATC Code Not Available
DrugBank ID DB09130
KEGG ID Not Available
MeSH ID D003300
PubChem ID 23978
TTD Drug ID D01WMJ
NDC Product Code 68428-349; 82815-0001; 62106-5020; 51285-204; 0220-1623; 0220-1635; 59365-5128; 68428-140; 64117-958; 0220-1636
UNII 789U1901C5
Synonyms Copper | Copper-63 | Copper 63
Chemical Information
Molecular Formula Cu
CAS Registry Number 7440-50-8
SMILES [Cu]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal adhesions12.02.03.006; 07.07.03.001-Not Available
Abdominal pain07.01.05.002-
Abdominal pain lower07.01.05.010-Not Available
Abdominal tenderness07.01.05.004-Not Available
Abortion18.01.01.001-Not Available
Abortion incomplete18.01.01.003-Not Available
Abortion infected18.01.03.002; 11.01.10.015--Not Available
Abortion missed18.01.01.002-Not Available
Abortion spontaneous18.01.04.001-Not Available
Acne cystic23.02.01.005-Not Available
Amenorrhoea21.01.02.001; 05.05.01.002-
Anaemia01.03.02.001--
Anhedonia19.15.02.007-Not Available
Anxiety19.06.02.002-
Back pain15.03.04.005--
Bartholin's cyst21.08.03.001; 16.04.04.003-Not Available
Benign hydatidiform mole18.05.03.001; 21.07.02.006; 16.04.01.002-Not Available
Breast discharge21.05.05.001-Not Available
Breast enlargement21.05.04.001-Not Available
Breast mass21.05.04.002-Not Available
Breast tenderness21.05.05.004-Not Available
Calculus bladder20.04.03.001-Not Available
Cervical discharge21.06.01.001-Not Available
Cervical dysplasia21.06.01.002-Not Available
Cervical polyp21.06.02.004; 16.04.05.001-Not Available
Cervix disorder21.06.01.003-Not Available
Cyst16.02.02.002; 08.03.05.001-Not Available
Dermatitis allergic23.03.04.003; 10.01.03.014--Not Available
Dermatitis atopic23.03.04.016; 10.01.04.004--Not Available
Device expulsion27.01.01.002--Not Available
The 1th Page    1 2 3 4 5    Next   Last    Total 6 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene